These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 497523)

  • 1. Some properties of 5-hydroxytryptamine receptors in the hindquarters of the rat.
    Cooper M; Wyllie JH
    Br J Pharmacol; 1979 Sep; 67(1):79-85. PubMed ID: 497523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some properties of 5-hydroxytryptamine receptors in the hindquarters of the rat [proceedings].
    Cooper M; Wyllie JH
    Br J Pharmacol; 1978 Nov; 64(3):389P. PubMed ID: 719247
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
    Calama E; Fernández MM; Morán A; Martín ML; San Román L
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation.
    Bond RA; Ornstein AG; Clarke DE
    J Pharmacol Exp Ther; 1989 May; 249(2):401-10. PubMed ID: 2724131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism by tetrahydro-beta-carboline of the vasoconstrictor responses to tryptamine in rat tail arteries.
    Hicks PE; Langer SZ
    Eur J Pharmacol; 1983 Dec; 96(1-2):145-9. PubMed ID: 6141059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
    Ogunbiyi PO; Eyre P
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of selective antagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta.
    Stollak JS; Furchgott RF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):215-21. PubMed ID: 6129317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptamine-induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5-hydroxytryptamine receptors.
    Bradley PB; Humphrey PP; Williams RH
    Br J Pharmacol; 1985 Apr; 84(4):919-25. PubMed ID: 3159458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb.
    Jandhyala BS; Kivlighn SD
    Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
    Marek GJ; Seiden LS
    J Pharmacol Exp Ther; 1988 Feb; 244(2):650-8. PubMed ID: 2894458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin receptors subserve only contraction in canine and rat pulmonary arteries and veins.
    Chand N; Altura BM
    Artery; 1980; 7(3):232-45. PubMed ID: 7469796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of noradrenaline and serotonin in a central and a peripheral artery in vitro.
    Tayo FM
    Afr J Med Med Sci; 1983; 12(3-4):139-43. PubMed ID: 6326547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual effect of dihydroergotamine at vascular 5-hydroxytryptamine receptors in pithed rats.
    Müller H; Glusa E; Markwardt F
    Pharmacology; 1988; 37(4):248-53. PubMed ID: 2904153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different hypothalamic receptors mediate 5-hydroxytryptamine- and tryptamine-induced core temperature changes in the rat.
    Cox B; Lee TF; Martin D
    Br J Pharmacol; 1981 Mar; 72(3):477-82. PubMed ID: 7260487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester.
    Roth BL; Nakaki T; Chuang DM; Costa E
    J Pharmacol Exp Ther; 1986 Aug; 238(2):480-5. PubMed ID: 3016238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.